comparemela.com
Home
Live Updates
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production : comparemela.com
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
cGMP Facility Streamlines Clinical & Commercial mRNA Drug Substance Development;
Built by mRNA & Industry Experts to Meet Demand for mRNA-based Medicine
...
Related Keywords
San Diego ,
California ,
United States ,
Kevin Lynch ,
Maravai Lifesciences ,
Exchange Commission ,
Nasdaq ,
Trilink Biotechnologies ,
Link Biotechnologies ,
Cuts Ribbon ,
New San Diego Facility ,
Late Phase ,
Substance Production ,
Sorrento Valley ,
Vice President ,
General Manager ,
Drew Burch ,
Nucleic Acid ,
Securities Litigation Reform Act ,
Annual Report ,
comparemela.com © 2020. All Rights Reserved.